Washington, 19 Nov 2023: Bayer is voluntarily recalling one lot of its cancer drug Vitrakvi (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles in the U.S. due to microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability ......
View Details

Related News

• Innovative Cancer Treatment may sometimes cause Cancer, US FDA. Says (01-12-2023)

---

• New NMC logo facing the wrath of Medical fraternity (01-12-2023)

---

• MP: Local pharma firms record an upside in overseas orders (01-12-2023)

---

• Karnataka’s draft biotech policy draws up efforts to chalk out transformative growth trajectory (01-12-2023)

---

• India so far approved 15 vaccines and five booster doses: CDSCO (01-12-2023)

---

• US FDA flags data manipulation, management failures in warning letter to Intas on import alert (01-12-2023)

---

• PCI to Pharmacy Council of India to launch revamped "DIGI-PHARMed" application today (01-12-2023)

---

• Ahmedabad Crime Branch arrested two people with banned tabs, intoxicating syrup (01-12-2023)

---

• How Patanjali rode on the shoulders of Big Media (30-11-2023)

---

• 5 Dead, 2 Hospitalized after Consuming Ayurvedic 'Kalmeghasav' in Gujarat (30-11-2023)

---